NanoString announced new products to advance COVID-19 disease research
On Jun. 16, 2020, NanoString Technologies announced the availability of new solutions to study the immune response in COVID-19 disease research. As part of an expanding portfolio of infectious disease research solutions, the nCounterᆴ Host Response Gene Expression Panel and COVID -19 Panel Plus spike-in provide a comprehensive analysis of the viral infection and immune response.>
New protein and RNA content available on the GeoMxᆴ Digital Spatial Profiler enable high-plex analysis of key biological pathways mapped to specific regions within infected tissues.
Tags:
Source: NanoString Technologies
Credit: